patent tim guilford glutathione Liposomal | Liposomal Products US20100316700A1 - Systemic administration of
Description
doi: 10.1177/0271678X15610584
When the reaction of TMD was conducted in the presence of 30 mM TEMP and 32 mM sorbate, no significant decrease in TEMPO was observed (data not shown)
As a result, an additional antiviral activity may be envisaged as a particularly relevant property for quercetin in clinical practice
V., Littman, D
